Jeffrey Su
President at Bioserv Corp.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alexis Nahama | M | - | 7 years | |
| Yue Wu | M | 62 | 8 years | |
| Zhi Li | M | - |
CLI Ventures
 CLI Ventures Investment ManagersFinance CLI Ventures (CLI Ventures) is a venture capital division of Cheerland Investment Group founded in 2014 by Zhi Li. The firm is headquartered in Palo Alto, California. | 10 years |
| Mark R. Brunswick | M | - | 7 years | |
| Taotao Zhao | F | - |
CLI Ventures
CLI Ventures Investment ManagersFinance CLI Ventures (CLI Ventures) is a venture capital division of Cheerland Investment Group founded in 2014 by Zhi Li. The firm is headquartered in Palo Alto, California. | 9 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jesse McCool | M | - |
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | - |
| Douglas J. Langston | M | 63 | 3 years | |
| Jerome Zeldis | M | 74 | 3 years | |
| Yan Wang | M | - |
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | - |
| Valerie McDonnal | F | - |
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | - |
| John Petricciani | M | - |
CancerVax Corp.
| - |
| Douglas O. Ebersole | M | 68 | 2 years | |
| Donald Morton | M | - |
CancerVax Corp.
| - |
| Martin Mattingly | M | 66 |
CancerVax Corp.
| 2 years |
| Massimiliano Ciferri Ceretti | M | 60 |
Carleton University
| 4 years |
| Victoria Dickenson | M | - |
Carleton University
| 3 years |
| Jim Doble | M | - |
Carleton University
| 1 years |
| Darren Serrao | M | 58 |
Carleton University
| 4 years |
| Scott Somerville | M | - |
Carleton University
| 4 years |
| Paul Stacey | M | - |
Carleton University
| 4 years |
| Farith bin Ahmad Rithauddeen | M | 51 |
Carleton University
| 4 years |
| Nader Sabbaghian | M | - |
Carleton University
| 4 years |
| Priya Mathur | F | - |
Carleton University
| 3 years |
| Peter Manojlovic | M | - |
Carleton University
| 1 years |
| Bruce Geddes | M | - |
Carleton University
| 4 years |
| Kevin Kerr | M | - |
Carleton University
| 4 years |
| Ratna Endang Soelistiowati | F | 63 |
Carleton University
| 1 years |
| Bryan Wilfrid Pilsworth | M | - |
Carleton University
| 4 years |
| Shawn P. Stapleton | M | - |
Carleton University
| 3 years |
| Bambang Rudijanto Tanoesoedibjo | M | 60 |
Carleton University
| 4 years |
| Justin Currie | M | - |
Carleton University
| 4 years |
| Hary Iswanto Tanoesoedibjo | M | 58 |
Carleton University
| 4 years |
| Keith Schaefer | M | 58 |
Carleton University
| 4 years |
| Michel Francoeur | M | - |
Carleton University
| 4 years |
| Robert Kirby | M | - |
Carleton University
| 4 years |
| Hosni Abbas Hosni Mohammed | M | 59 |
Carleton University
| 3 years |
| Michael James McAuley | M | - |
Carleton University
| 4 years |
| Robert O’Brien | M | - |
Carleton University
| 5 years |
| Craig Loverock | M | 54 |
Carleton University
| 4 years |
| David Thomas | M | - |
Carleton University
| 8 years |
| Hatem Francis Ayyad | M | 54 |
Carleton University
| 4 years |
| Yuen Fan Chu | F | 54 |
Carleton University
| 4 years |
| Lori O'Neill | F | 58 |
Carleton University
| 4 years |
| Karla Thorpe | F | - |
Carleton University
| 5 years |
| Shek Fai Wong | M | 51 |
Carleton University
| 4 years |
| Bruce Belyea | M | - |
Carleton University
| 4 years |
| Les Kondejewski | M | - |
Carleton University
| 4 years |
| Alain Toto | M | - |
Carleton University
| 4 years |
| Craig Sweeney | M | - |
Carleton University
| 4 years |
| Mike Philbrick | M | - |
Carleton University
| 4 years |
| Brian Gusko | M | 57 |
Carleton University
| 4 years |
| Thomas Pinto Basto | M | - |
Carleton University
| 5 years |
| Eric Brouwer | M | - |
Carleton University
| 4 years |
| Cam Garner | M | 75 |
CancerVax Corp.
| 1 years |
| Chung Keung Loo | M | 61 |
Carleton University
| 2 years |
| Craig Ross | M | - |
Carleton University
| 4 years |
| Robert David Lyon | M | - |
Carleton University
| 4 years |
| Charles Chi | M | - |
Carleton University
| 4 years |
| Byron Berry | M | - |
Carleton University
| 1 years |
| Michael Christodoulou | M | - |
Carleton University
| 4 years |
| Nicholas John Christodoulou | M | - |
Carleton University
| 4 years |
| Edward L. Merchand | M | 61 |
Carleton University
| 4 years |
| Brent Arthur Sutton | M | - |
Carleton University
| 1 years |
| Eugene J. Lundrigan | M | - |
Carleton University
| 4 years |
| Phillip Schneider | M | 68 |
CancerVax Corp.
| 3 years |
| Barclay Phillips | M | 61 |
CancerVax Corp.
| 6 years |
| Steven J. Ruhl | M | - |
CancerVax Corp.
| - |
| David Thomas | M | 67 |
Carleton University
| 8 years |
| Carol R. Jensen | M | 71 | 3 years | |
| Jeffrey Steven Silverman | M | - |
CancerVax Corp.
| 1 years |
| Carol Gallagher | M | 59 |
CancerVax Corp.
| 3 years |
| Martha S. Preston | F | - |
CancerVax Corp.
| - |
| Dennis E. van Epps | M | - |
CancerVax Corp.
| - |
| Robert E. Kiss | M | - |
CancerVax Corp.
| - |
| Guy M. Gammon | M | - |
CancerVax Corp.
| - |
| Debra J. Arnold | F | - |
CancerVax Corp.
| - |
| William LaRue | M | 73 |
CancerVax Corp.
| 5 years |
| Eric W. Goldstrand | M | - |
Carleton University
| 4 years |
| Tanya S. Kanigan | M | - |
Carleton University
| 4 years |
| Darin Wagner | M | 59 |
Carleton University
| 1 years |
| Paul Gasperetti | M | - |
Carleton University
| 4 years |
| Ivor Royston | M | 79 |
CancerVax Corp.
| - |
| Peter Chiappinelli | M | - |
Carleton University
| 4 years |
| Theodore O. Ebel | M | 54 |
CancerVax Corp.
| 5 years |
| Carlos Manuel Yuste | M | - |
Carleton University
| 1 years |
| Andy McEachern | M | - |
Carleton University
| 4 years |
| Gerry A. Belgraver | M | - |
Carleton University
| 4 years |
| Greylock Charles | M | - |
Carleton University
| 4 years |
| Matthew Olivier | M | - |
Carleton University
| 4 years |
| Scott Knight | M | - |
Carleton University
| 4 years |
| Michael Moore | M | 56 |
Carleton University
| 4 years |
| Fareed A. Khan | M | 58 |
Carleton University
| 4 years |
| Catharine Farrow | M | 59 |
Carleton University
| 3 years |
| Edward Keyes | M | - |
Carleton University
| 1 years |
| Mark O'Dea | M | 56 |
Carleton University
| 4 years |
| Carl Alexander von Einsiedel | M | 66 |
Carleton University
| 4 years |
| Jason King Dunning | M | - |
Carleton University
| 4 years |
| Cory Kent | M | 55 |
Carleton University
| 4 years |
| Mike Mazan | M | 56 |
Carleton University
| 4 years |
| Elizabeth Ann Fagan | M | 74 |
Tanox, Inc.
 Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 70 | 70.00% |
| United States | 30 | 30.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jeffrey Su
- Personal Network
